Clinical Trials Directory

Trials / Completed

CompletedNCT01340404

Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral Vasculopathy

A Multicenter Study Comparing the Results of Allogeneic Stem Cell Genoidentical in Children With Sickle Cell Anemia and Cerebral Vascular Disease Detected by Transcranial Doppler

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Assistance Publique - Hôpitaux de Paris · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to demonstrate that cerebral velocities assessed by transcranial doppler (TCD) are more significantly decreased by SCT than by long-term transfusion program A multicenter, national, non-randomized, prospective study of paired cohort will be conducted, with 2 groups of exposed (SCT) and non-exposed (TP) patients.

Detailed description

The aim of this study is to demonstrate that cerebral velocities assessed by transcranial doppler (TCD)are more significantly decreased by SCT than by long-term transfusion program A multicenter, national, non-randomized, prospective study of paired cohort will be conducted, with 2 groups of exposed (SCT) and non-exposed (TP) patients. Sixty-three patients will be enrolled, namely 21 sickle-cell patients in the "SCT" group and 42 in the "Transfusion Program (TP)" group

Conditions

Interventions

TypeNameDescription
PROCEDUREStem cell transplantationStem cell transplantation
PROCEDURETransfusion programTransfusion program

Timeline

Start date
2010-12-01
Primary completion
2013-04-01
Completion
2015-10-01
First posted
2011-04-22
Last updated
2016-12-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01340404. Inclusion in this directory is not an endorsement.